Posts about

hiv

Glycan profiles of gp120 protein vaccines from four major HIV-1 subtypes produced from different host cell lines under non-GMP or GMP conditions.

Glycan profiles of gp120 protein vaccines from four major HIV-1 subtypes produced from different host cell lines under non-GMP or GMP conditions.

Products Related Product# 1039 HIV-1 YU2 (M Tropic)Envelope Glycoprotein gp41 Product# 1081 HIV-1 gp120 (ADA) Product# 1011 HIV-1 gp120 (subtype C) Product# 1031 HIV-1 gp120 (YU2) Abstract Envelope glycoprotein (Env) of human immunodeficiency virus type 1 (HIV-1) is an important target for the development of an HIV vaccine. Extensive glycosylation of Env is an.

ImmunoDX
Read More
DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers

DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers

Products Related to p24, gp41, gp120, gp160     Product# 1103 HIV-1 p24 Monoclonal Antibody   Product#1091 Recombinant HIV-1 MN gp41 Envelope Protein (E.coli)   Product#1001 Recombinant HIV-1 IIIB Envelope Glycoprotein gp120 (Baculovirus)     Product#1024 Recombinant HIV-1 MN Envelope Glycoprotein gp160 (Baculovirus) INTRODUCTION It is generally believed that.

ImmunoDX
Read More
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.

Products Related   Product# 101 gp120 Capture Elisa Kit   Product# 1081 HIV-1 gp120 (ADA)   Product# 1011 HIV-1 gp120 (subtype C) INTRODUCTION Entry is the first step of the human immunodeficiency virus type 1 (HIV-1) replication cycle and requires the mature viral envelope glycoproteins (Env), which results from the proteolytic cleavage of the gp160 precursor Env.

ImmunoDX
Read More
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates

ImmunoDX
Read More
Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.

Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.

Products Related   Product# 101 gp120 Capture Elisa Kit   Product# 1081 HIV-1 gp120 (ADA)   Product# 1011 HIV-1 gp120 (subtype C) INTRODUCTION The HIV-1 envelope (Env) complex of glycoproteins gp120 and gp41 is the target for neutralizing antibodies (nAbs) induced in HIV-1-infected patients and for HIV/AIDS vaccine development (1, 2). Glycoprotein gp120 has been.

ImmunoDX
Read More
Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein

Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein

Introduction HIV-1 Env3 is a trimer of heterodimers of gp120 and gp41 that are associated non-covalently after cleavage of gp160 by an endogenous protease (1). The trimeric Env on the HIV-1 surface facilitates viral entry into the host cell through receptors and is the target of neutralizing antibodies (2). In some rare subjects, broadly neutralizing antibodies (bNAbs) are spontaneously.

ImmunoDX
Read More
Adaptation of HIV-1 to cells with low expression of the CCR5 co-receptor.

Adaptation of HIV-1 to cells with low expression of the CCR5 co-receptor.

Products Related       Product# 1039 HIV-1 YU2 (M Tropic)Envelope Glycoprotein gp41   Product# 1081 HIV-1 gp120 (ADA)   Product# 1011 HIV-1 gp120 (subtype C)   Product# 1031 HIV-1 gp120 (YU2) Introduction The metastable human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimer ((gp120/gp41)3) mediates entry into target cells (Wyatt and Sodroski,.

ImmunoDX
Read More
HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms

HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms

Products Related to gp120, Nef, Vif     Product# 2501 Human Anti-gp120/160 HIV-1 pAb IgG     Product# 1008 Recombinant HIV-1 nef (E.coli) Product# 1007 Recombinant HIV-1 vif (E.coli)   INTRODUCTION HIV-1 infection is characterized by both chronic immune activation and severe CD4 T cell loss, eventually progressing to AIDS. After more than 30 years of research,.

ImmunoDX
Read More
The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel

The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel

Products Related   Product#1039 HIV-1 YU2 (M Tropic)Envelope Glycoprotein gp41   Product# 101 gp120 Capture Elisa Kit   Product# 1081 HIV-1 gp120 (ADA)   Product# 1011 HIV-1 gp120 (subtype C)   INTRODUCTION The HIV-1 envelope (Env) glycoprotein complex, consisting of glycoproteins gp120 and gp41, mediates the virus entry into the host cell. This heterotrimer.

ImmunoDX
Read More
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis

Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis

Products Related to p24, gp41, gp120, gp160     Product# 1103 HIV-1 p24 Monoclonal Antibody   Product#1091 Recombinant HIV-1 MN gp41 Envelope Protein (E.coli)   Product#1001 Recombinant HIV-1 IIIB Envelope Glycoprotein gp120 (Baculovirus)     Product#1024 Recombinant HIV-1 MN Envelope Glycoprotein gp160 (Baculovirus) Abstract Oral fluid (OF) is a highly.

ImmunoDX
Read More
101 results